Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome

Detalles Bibliográficos
Autores principales: Proietti, Ilaria, Tolino, Ersilia, Bernardini, Nicoletta, Di Fraia, Marco, Skroza, Nevena, Potenza, Concetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412024/
https://www.ncbi.nlm.nih.gov/pubmed/37557104
http://dx.doi.org/10.5826/dpc.1303a178
_version_ 1785086792248066048
author Proietti, Ilaria
Tolino, Ersilia
Bernardini, Nicoletta
Di Fraia, Marco
Skroza, Nevena
Potenza, Concetta
author_facet Proietti, Ilaria
Tolino, Ersilia
Bernardini, Nicoletta
Di Fraia, Marco
Skroza, Nevena
Potenza, Concetta
author_sort Proietti, Ilaria
collection PubMed
description
format Online
Article
Text
id pubmed-10412024
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-104120242023-08-10 Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome Proietti, Ilaria Tolino, Ersilia Bernardini, Nicoletta Di Fraia, Marco Skroza, Nevena Potenza, Concetta Dermatol Pract Concept Letter to the Editor Mattioli 1885 2023-07-01 /pmc/articles/PMC10412024/ /pubmed/37557104 http://dx.doi.org/10.5826/dpc.1303a178 Text en ©2023 Proietti et al. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited.
spellingShingle Letter to the Editor
Proietti, Ilaria
Tolino, Ersilia
Bernardini, Nicoletta
Di Fraia, Marco
Skroza, Nevena
Potenza, Concetta
Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome
title Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome
title_full Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome
title_fullStr Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome
title_full_unstemmed Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome
title_short Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome
title_sort efficacy of cemiplimab in a patient affected by cutaneous squamous cell carcinoma and myelodysplastic syndrome
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412024/
https://www.ncbi.nlm.nih.gov/pubmed/37557104
http://dx.doi.org/10.5826/dpc.1303a178
work_keys_str_mv AT proiettiilaria efficacyofcemiplimabinapatientaffectedbycutaneoussquamouscellcarcinomaandmyelodysplasticsyndrome
AT tolinoersilia efficacyofcemiplimabinapatientaffectedbycutaneoussquamouscellcarcinomaandmyelodysplasticsyndrome
AT bernardininicoletta efficacyofcemiplimabinapatientaffectedbycutaneoussquamouscellcarcinomaandmyelodysplasticsyndrome
AT difraiamarco efficacyofcemiplimabinapatientaffectedbycutaneoussquamouscellcarcinomaandmyelodysplasticsyndrome
AT skrozanevena efficacyofcemiplimabinapatientaffectedbycutaneoussquamouscellcarcinomaandmyelodysplasticsyndrome
AT potenzaconcetta efficacyofcemiplimabinapatientaffectedbycutaneoussquamouscellcarcinomaandmyelodysplasticsyndrome

Ejemplares similares